|

HWK-016, MUCIN-16-targeted ADC Clinical Trials

1 actively recruiting trial across 1 location

Also known as: HWK-016

Pipeline

Phase 1: 1

Top Sponsors

  • Whitehawk Therapeutics, Inc.1

Indications

  • PROC1
  • Platinum-resistant Ovarian Cancer1
  • Endometrial Cancer1
  • Cancer1

Little Rock, Arkansas1 trial

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

University of Arkansas - Winthrop P. Rockefeller Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.